Skip to Main Content

WASHINGTON — BIO CEO Jim Greenwood won’t admit last month’s midterm elections spell trouble for the drug industry.

Despite Democrats taking control of the House of Representatives, floating splashy legislation and openly threatening to investigate drug companies, Greenwood says that come January, he’s going to march into Democrat’s offices and unapologetically sing the praises of the drug industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!